Hanall Biopharma Co. on Thursday reported its second-quarter net loss of 3.3 billion won (US$2.4 million), shifting from a profit of 7.3 billion won a year earlier. The company said in a regulatory filing that it posted an operating loss of 3.1 billion won for the April-June period, compared with a profit of 8.1 billion won a year ago. Revenue fell 23.7 percent to 31.6 billion won. Source: Yonhap News Agency
Hanall Biopharma swings to loss in Q2
Recent News
Taichung MRT Cars from Fatal 2023 Crash to Be Auctioned Off
November 19, 2026
Study Links Obesity and Fried Foods to Accelerated Biological Aging
November 19, 2026
MOENV Repair Vouchers Claimed Rapidly After Release
November 19, 2026
MOENV’s Repair Voucher Program Sees Rapid Uptake in Taiwan
November 19, 2026
MOENV’s Repair Vouchers Quickly Claimed in Tainan and Taoyuan
November 19, 2026
Taichung MRT Cars from 2023 Crane Accident Set for Auction
November 19, 2026